Dr. Chen is a leading researcher in metabolic health and gene therapy, with over 15 years of experience in clinical trials for sickle cell disease and diabetes. She has published 200+ peer-reviewed papers and holds 12 patents in precision medicine.
247
Articles
18,420
Citations
62
h-index
34,500
Followers
CRISPR Gene Therapy Achieves 94% Cure Rate for Sickle Cell Disease
High-fidelity CRISPR-Cas9 therapy achieves 94% cure rate with complete elimination of sickle cell crises.
Metabolic Reprogramming in Type 2 Diabetes via Targeted Gene Editing
Novel approach to restoring insulin sensitivity through targeted epigenetic modifications.
Continuous Glucose Monitoring Reduces HbA1c by 1.2% in Real-World Study
Large-scale real-world evidence confirms CGM benefits across diverse patient populations.
Gut Microbiome Signatures Predict Metabolic Syndrome Risk
Machine learning identifies 12 microbial biomarkers that predict metabolic syndrome 3 years before onset.
Precision Nutrition Based on Glycemic Response Patterns
Personalized dietary recommendations based on individual glycemic variability improve outcomes.
Education
MD, PhD
Harvard Medical School · 2008
Residency
Johns Hopkins Hospital · 2012
Fellowship
Stanford Medicine · 2014
Quick Links
Dr. Chen is a leading researcher in metabolic health and gene therapy, with over 15 years of experience in clinical trials for sickle cell disease and diabetes. She has published 200+ peer-reviewed papers and holds 12 patents in precision medicine.
247
Articles
18,420
Citations
62
h-index
34,500
Followers
CRISPR Gene Therapy Achieves 94% Cure Rate for Sickle Cell Disease
High-fidelity CRISPR-Cas9 therapy achieves 94% cure rate with complete elimination of sickle cell crises.
Metabolic Reprogramming in Type 2 Diabetes via Targeted Gene Editing
Novel approach to restoring insulin sensitivity through targeted epigenetic modifications.
Continuous Glucose Monitoring Reduces HbA1c by 1.2% in Real-World Study
Large-scale real-world evidence confirms CGM benefits across diverse patient populations.
Gut Microbiome Signatures Predict Metabolic Syndrome Risk
Machine learning identifies 12 microbial biomarkers that predict metabolic syndrome 3 years before onset.
Precision Nutrition Based on Glycemic Response Patterns
Personalized dietary recommendations based on individual glycemic variability improve outcomes.
Education
MD, PhD
Harvard Medical School · 2008
Residency
Johns Hopkins Hospital · 2012
Fellowship
Stanford Medicine · 2014